Paper23710641
Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.
Jeong SJ and 4 others. Crit Care, 2013. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Papers, record 23710641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23710641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal, Humanized | Major topic |
| Disease Models, Animal | Major topic |
| Sepsis | Major topic |
| Vascular Endothelial Growth Factor A | Major topic |
| Animals | |
| Bevacizumab | |
| Human Umbilical Vein Endothelial Cells | |
| Humans | |
| Inflammation | |
| Lipopolysaccharides | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 28676101 | Does anti-VEGF bevacizumab improve survival in experimental sepsis? | https://conductscience.org/library/papers/28676101 |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21316568 | Microcirculatory dysfunction in sepsis. | Crit Care Nurs Clin North Am | 2011 | https://conductscience.org/library/papers/21316568 | PubMed |
| 2 | 9537336 | Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. | Circulation | 1998 | https://conductscience.org/library/papers/9537336 | PubMed |
| 3 | 16997427 | Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. | Neurochem Int | 2007 | https://conductscience.org/library/papers/16997427 | PubMed |
| 4 | 18461451 | The septic brain. | Neurochem Res | 2008 | https://conductscience.org/library/papers/18461451 | PubMed |
| 5 | 15614129 | Plasma vascular endothelial growth factor in severe sepsis. | Shock | 2005 | https://conductscience.org/library/papers/15614129 | PubMed |
| 6 | 15776385 | CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15776385 | PubMed |
| 7 | 6823562 | Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. | Science | 1983 | https://conductscience.org/library/papers/6823562 | PubMed |
| 8 | 9734938 | Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. | Lancet | 1998 | https://conductscience.org/library/papers/9734938 | PubMed |
| 9 | 12231573 | Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients. | Arterioscler Thromb Vasc Biol | 2002 | https://conductscience.org/library/papers/12231573 | PubMed |
| 10 | 22616830 | Drotrecogin alfa (activated) in adults with septic shock. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22616830 | PubMed |
| 11 | 10504372 | Experimental study of intraperitoneal suramin on the healing of colonic anastomoses. | Br J Surg | 1999 | https://conductscience.org/library/papers/10504372 | PubMed |
| 12 | 12427750 | NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12427750 | PubMed |
| 13 | 9377574 | Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. | Cancer Res | 1997 | https://conductscience.org/library/papers/9377574 | PubMed |
| 14 | 16258121 | Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16258121 | PubMed |
| 15 | 8797612 | INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. | Crit Care Med | 1996 | https://conductscience.org/library/papers/8797612 | PubMed |
| 16 | 15136787 | Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. | Nat Rev Drug Discov | 2004 | https://conductscience.org/library/papers/15136787 | PubMed |
| 17 | 11108718 | Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11108718 | PubMed |
| 18 | 15660511 | Therapeutic intervention and targets for sepsis. | Annu Rev Med | 2005 | https://conductscience.org/library/papers/15660511 | PubMed |
| 19 | 16156153 | Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. | Ophthalmic Surg Lasers Imaging | 2005 | https://conductscience.org/library/papers/16156153 | PubMed |
| 20 | 10837361 | Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. | Am J Respir Cell Mol Biol | 2000 | https://conductscience.org/library/papers/10837361 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42827248 | Targeting capillary leak in experimental sepsis and endotoxemia: a systematic review of therapeutic agents, methods and models in animal studies. | Crit Care | 2026 | https://conductscience.org/library/papers/42827248 | PubMed |
| 42827140 | Coordinated response of vascular and glial cells in a pig model of sepsis. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/42827140 | PubMed |
| 42201618 | Ameliorative effects of bevacizumab against sepsis-induced acute kidney injury: investigation of inflammatory responses, pyroptosis-related signalling and angiogenesis in a murine model of polymicrobial sepsis. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42201618 | PubMed |
| 41123708 | Bevacizumab alleviates kidney damage by modulating inflammation, necroptosis and apoptosis: a preclinical study of renal ischaemia/reperfusion injury in rats. | J Mol Histol | 2025 | https://conductscience.org/library/papers/41123708 | PubMed |
| 38313162 | Targeting VEGF using Bevacizumab attenuates sepsis-induced liver injury in a mouse model of cecal ligation and puncture. | J Med Life | 2023 | https://conductscience.org/library/papers/38313162 | PubMed |
| 38020105 | Organotypic heterogeneity in microvascular endothelial cell responses in sepsis-a molecular treasure trove and pharmacological Gordian knot. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38020105 | PubMed |
| 37520007 | Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/37520007 | PubMed |
| 37085944 | Serum vascular endothelial growth factor affects tissue fluid accumulation and is associated with deteriorating tissue perfusion and oxygenation in severe sepsis: a prospective observational study. | Eur J Med Res | 2023 | https://conductscience.org/library/papers/37085944 | PubMed |
| 36797542 | Fibulin2: a negative regulator of BMSC osteogenic differentiation in infected bone fracture healing. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/36797542 | PubMed |
| 36580009 | Nanotherapy: New Approach for Impeding Hepatic Cancer Microenvironment via Targeting Multiple Molecular Pathways. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/36580009 | PubMed |
| 36565333 | ADAM10-a "multitasker" in sepsis: focus on its posttranslational target. | Inflamm Res | 2023 | https://conductscience.org/library/papers/36565333 | PubMed |
| 36188562 | Sepsis-induced AKI: From pathogenesis to therapeutic approaches. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36188562 | PubMed |
| 36188533 | Identification of the key ferroptosis-related genes involved in sepsis progression and experimental validation in vivo. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36188533 | PubMed |
| 36016936 | Erythropoietin mediates re-programming of endotoxin-tolerant macrophages through PI3K/AKT signaling and protects mice against secondary infection. | Front Immunol | 2022 | https://conductscience.org/library/papers/36016936 | PubMed |
| 35910890 | The rs8506 TT Genotype in lincRNA-NR_024015 Contributes to the Risk of Sepsis in a Southern Chinese Child Population. | Front Public Health | 2022 | https://conductscience.org/library/papers/35910890 | PubMed |
| 35634305 | Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design. | Front Immunol | 2022 | https://conductscience.org/library/papers/35634305 | PubMed |
| 35438589 | Cord Blood Natural Killer Cells Inhibit Sepsis Caused by Feces-Induced Acute Peritonitis via Increasing Endothelium Integrity. | Cell Transplant | 2022 | https://conductscience.org/library/papers/35438589 | PubMed |
| 35222366 | Inactivation of AUF1 in Myeloid Cells Protects From Allergic Airway and Tumor Infiltration and Impairs the Adenosine-Induced Polarization of Pro-Angiogenic Macrophages. | Front Immunol | 2022 | https://conductscience.org/library/papers/35222366 | PubMed |
| 34667283 | Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury. | Nat Rev Nephrol | 2022 | https://conductscience.org/library/papers/34667283 | PubMed |
| 33550460 | Refractory severe idiopathic systemic capillary leak syndrome successfully treated with bevacizumab: a case report. | Angiogenesis | 2021 | https://conductscience.org/library/papers/33550460 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23710641
GET https://conductscience.org/api/papers/v1/23710641/references?page=2